期刊文献+

氯诺昔康全子宫切除术后自控镇痛及其对β内啡肽的影响

Analgesia effects of lornoxicam on postoperative total hysterectomy pain and influence on beta-endorphin serum concentration
下载PDF
导出
摘要 目的:评价氯诺昔康用于全子宫切除术后自控镇痛(PCA)的效果和安全性,并观察其对β内啡肽水平的影响。方法:60例全麻下行全子宫切除术术后中度以上疼痛的病人随机分为氯诺昔康组和吗啡组。根据需要启动PCA泵,分别给予氯诺昔康每次0.8mg,吗啡每次1mg,锁定时间5min。以疼痛缓解程度、疼痛缓解总和及24h镇痛总体效果来评价镇痛效果,同时测定血浆β内啡肽、皮质醇浓度。结果:氯诺昔康组与吗啡组的疼痛缓解总和及镇痛总体印象评分无显著差异(P>0.05),吗啡组起效早于氯诺昔康组(P<0.01)。氯诺昔康组的呕吐的发生率明显低于吗啡组(P<0.01)。2组血小板聚集率无显著差异(P>0.05)。启动镇痛泵后3h,2组β内啡肽皆有显著上升,2组间没有显著差异(P>0.05)。结论:氯诺昔康用于全子宫切除术后PCA,效应与吗啡相当,不良反应较少。氯诺昔康可引起β内啡肽的显著升高,其机制有待探讨。 AIM:To assess the analgesic efficacy and safety of lomoxicam on patient-controlled analgesia (PCA) undergoing hysterectomy and influence of lomoxicam on beta-endorphin serum concentration.METHODS: Sixty patients scheduled for abdominal hysterectomy under general anaesthesia were randomly divided into lornoxicam group and morphine group.According to the necessity, two drugs administered ivvia a patient-controlled analgesia for up to 24 h, postoperatively ( lornoxicam group, bolus = 0.8 mg lornoxicam , lock-out time 5 min. monphine group, bolus =1 mg morphine, lock-out time 5 min). Efficacy was assessed by comparing hourly pain relief (PAR), total pain relief (TOTPAR)and patient's evaluation of the efficacy of PCA received. Adverse reactions like vomiting, respiratory depression and abdominal distension were also observed. Platelet aggregation with functions of kidney and liver were monitored. Beta-endorphin and cortisol concentrations were measured before and after the operation. RESULTS. There were no statistically significant difference between the two groups in TOTPAR and patient's general evaluation of the efficacy (P 〉 0.05 ). Lornoxicam caused fewer adverse reactions such as vomiting than morphine ( P 〈 0.01 ).Statistical analysis also revealed no significant difference in platelet aggregation (P 〉 0.05 ). Concentrations of beta-endorphin increased significantly in both groups 3 h after PCA start ( P 〈 0.01 ), and there were no statistically significant difference between the two groups (P 〉 0.05). CONCLUSION : Lornoxicam offers an useful alternative to morphine for the PCA withless adverse reactions. Lornoxicam can induce the notable increase of beta-endorphin under stress which needs further study.
出处 《中国新药与临床杂志》 CAS CSCD 北大核心 2005年第8期656-659,共4页 Chinese Journal of New Drugs and Clinical Remedies
关键词 消炎药 非甾类 镇痛 病人控制 Β内啡肽 随机对照试验 双盲法 氯诺昔康 anti-inflammatory agents, nonsteroidal analgesia, patient-controlled beta-endorphin randomized controlled trials double-blind method lornoxicam
  • 相关文献

参考文献7

  • 1龚志毅,叶铁虎,于广祥,秦晓涛,郭向阳,罗爱伦.氯诺昔康用于妇科开腹手术后病人自控镇痛的临床研究[J].中华麻醉学杂志,2001,21(9):531-533. 被引量:121
  • 2McCRORY CR, LINDAHL SG. Cyclooxygenase inhibition for postoperative analgesia [J]. Anesth Analg,2002,95 ( 1 ): 169-176.
  • 3RADHOFER-WELTE S, RABASSEDA X. Lornoxicam, a new potent NSAID with an improved tolerability profile [J]. Drugs Today (Barc) ,2000,36( 1 ) :55-76.
  • 4AVERBUCH M, KATZPER M. Baseline pain and response to analgesic medications in the postsurgery dental pain model [J]. J Clin Pharmacol, 2000, 40(2):133-137.
  • 5ROSENOW DE, ALBRECHTSEN M, STOLKE D. A comparison of patient-controlled analgesia with lornoxicam versus morphine in patients undergoing lumbar disk surgery[ J]. Anesth Analg, 1998, 86(5): 1045-1050.
  • 6KULLICH W, KLEIN G. Influence of the nonsteroidal anti-inflammatory drug locnoxicam on the secretion of the endogenous opiate peptides dynorphin and β-endorphin [ J ]. Aktuel Rheumato, 1992,17(2) :128-132.
  • 7TROULLOS E, HARGREAVES KM, DIONNE RA, et al. Ibuprofen elevates immunoreactive beta-endorphin levels in humans during surgical stress[J]. Clin Pharmacol Ther, 1997,62( 1 ) :74-81.

二级参考文献7

  • 1Pruss TP,Stoiβnig H,Radhofer Welte S,et al.Overview of the pharmacological properties, pharmacokinetics and animal safety assessment of lornoxicam[].Postgraduate Medical Journal.1990
  • 2Olkkola KT,Brunetto AV,Mattila MJ.Pharmacokinetics of oxicam nonsteroidal anti-inflammatory agents[].Clinical Pharmacokinetics.1994
  • 3Nuutinen LS,Laitinen JO,Salomaki TE.A risk-benefit appraisal of injectable NSAIDs in the management of postoper-ative pain[].Drug Safety.1993
  • 4Kullich W,Klein G.Influence of the nonsteroidal anti-inflammatory drug lornoxicam on the secretion of the endogenous opiate peptides dynorphin andβ-endorphin[].Aktuelle Rheumatologie.1992
  • 5Detlef ER,Morten A,Diet mars.A comparison of patient-con-trolled analgesia withlornoxicam versus morphine in patients un-dergoing lumbar disk surgery[].Anesthesia and Analgesia.1998
  • 6Norholt SE,Sindet-Pedersen S,Larsen U,et al.Pain control after dental surgery: a double blind, randomised trial of lornoxicam versus morphine[].Pain.1996
  • 7Berg J,Christoph T,Widerna M,et al.Isoenzyme-specific cyclooxygenase inhibitors:a whole cell assay system using the human erythroleukemic cell line HEL and the human monocytic cell line Mono Mac6[].Journal of Pharmacological and Toxicological Methods.1997

共引文献120

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部